Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) Rises 1.51% Intraday, NAV Per Unit at HK$11.971

NewTimeSpace News: As of 14:38 on June 10, 2026, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) gained 1.51% to HK$12.140. The ETF traded 4,439,800 shares with a turnover of HK$53.0698 million and an average trading price of HK$11.953. Its current net asset value per unit is HK$11.971, total assets reach HK$1.858 billion, and each trading lot contains 100 shares.

Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) tracks the Hang Seng Biotechnology Index. Its constituent stocks focus on pharmaceuticals, biotechnology, medical devices and other related sectors.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.